Evaluation of stability and potency of live attenuated rinderpest vaccine of lapinized-avianized tissue culture strain origin for the establishment of expiration period

가토화·계태화 우역 생백신의 유효기간 설정을 위한 안정성 및 효능 평가

  • Yeh, Jung-Yong (National Veterinary Research and Quarantine Service) ;
  • Kim, Hyun-Ju (National Veterinary Research and Quarantine Service) ;
  • Nah, Jin-Ju (National Veterinary Research and Quarantine Service) ;
  • Park, Jee-Yong (National Veterinary Research and Quarantine Service) ;
  • Lee, Ji-Hye (National Veterinary Research and Quarantine Service) ;
  • Seo, Hyun-Ji (National Veterinary Research and Quarantine Service) ;
  • Kweon, Chang-Hee (National Veterinary Research and Quarantine Service) ;
  • Cho, In-Soo (National Veterinary Research and Quarantine Service) ;
  • Moon, Jin-San (National Veterinary Research and Quarantine Service)
  • Accepted : 2009.09.16
  • Published : 2009.09.30

Abstract

In this study, we evaluated the stability and potency of live attenuated rinderpest vaccines of lapinized-avianized tissue culture strain origin, which had been produced annually from 2005 to 2008. When immune responses to the vaccines were evaluated using two Holstein calves weighing 100~150 kg, neutralizing antibody titer of 1 : 16 was induced at 21 days post vaccination. When calves were also inoculated with vaccines lots that had been stored for 39 months at ${4^{\circ}C}$, same level of antibody titer was observed. Using the virus titer test, we found that all batches of the vaccine that had been kept for 3, 10, 15, 22, 27, 34, 39, and 45 months showed no significant loss of titers, and fulfilled the requirement necessary ($\geq$ 3 $logTCID_50$) to be used as the national rinderpest vaccine reserve in Korea. In this study, we demonstrated that stability and potency of the rinderpest vaccines were maintained over three years when kept at ${4^{\circ}C}$ storage. This indicates that it maybe feasible to extend the expiration period of this vaccine from one year to three years.

Keywords

References

  1. 국립수의과학검역원. 동물용 생물학적제제 기준(안). 우역 생백신. pp. 48-52, 국립수의과학검역원, 안양, 2004
  2. 국립수의과학검역원. 국가검정 동물용의약품 검정기준. 우역(조직배양) 생건조백신 검정기준. pp. 78-79, 국립수의과학검역원, 안양, 2009
  3. 권혁진, 김두희, 임영문, 이창구, 강병직. 조직배양우 역 생독백신개발에 관한 시험. 농사시험연구보고 21. pp. 1-9, 농촌진흥청, 수원, 1979
  4. 농촌진흥청. 한국의 가축위생 연구(가축위생연구소 80년사). 우역. pp. 125-130, 농촌진흥청, 수원, 1991
  5. 문재봉, 이남신, 김정규. 연속계대에 있어서의 조화 우역독(LA)과 가토화 우역독(L)의 여러 숙주에 대한 태도. 가축위생연구소보 5. pp. 7-14, 농촌진흥청, 수원, 1961
  6. 문재봉, 마점술. 우역 예방약에 관한 연구. 가축위생 연구소보 8. pp. 88-95, 농촌진흥청, 수원, 1962
  7. 이남신, 김정규. 발육란에 우역 병독의 감염시험. 농 림부 중앙가축위생연구소 연구보고 2. pp. 1-10, 농림부, 서울, 1954
  8. Choi KS, Kwon CH, Choi CU, Lee JG, Kang YB. Biological properties of attenuated rinderpest virus (LATC strain) adapted in Vero cell. RDA J Vet Sci 1998, 40, 61-70
  9. Diop BA, Bastiaensen P. Achieving full eradication of rinderpest in Africa. Vet Rec 2005, 157, 239-240
  10. Huygelen C. The immunization of cattle against Rinderpest in Eighteenth-century Europe. Med Hist 1997, 41, 182-196 https://doi.org/10.1017/S0025727300062372
  11. Karber G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch Exp Pathol Pharmacol 1931, 162, 480-483 https://doi.org/10.1007/BF01863914
  12. Plowright W, Ferris RD. Studies with rinderpest virus in tissue culture. The use of attenuated culture virus as a vaccine for cattle. Res Vet Sci 1962, 3, 172-182
  13. Rossiter PB, Jessett DM, Taylor WP. Microneutralisation systems for use with different strains of peste des petits ruminants virus and rinderpest virus. Trop Anim Health Prod 1985, 17, 75-81 https://doi.org/10.1007/BF02360775
  14. Wamwayi HM, Rossiter PB, Wafula JS. Confirmation of rinderpest in experimentally and naturally infected cattle using microtitre techniques. Trop Anim Health Prod 1991, 23, 17-21 https://doi.org/10.1007/BF02361264